NEW YORK (Reuters Health) – A portable magnetic stimulation device is a promising noninvasive, drug-free treatment for acute migraine with aura, according to a March 4th online report…
NEW YORK (Reuters Health) – Ethosuximide and valproic acid are more effective than lamotrigine for treating childhood absence epilepsy, the most common pediatric epilepsy syndrome, according to a…
NEW YORK (Reuters Health) – Asymptomatic patients with a low ankle brachial index don’t seem to get cardiovascular protection from aspirin, randomized trial results suggest. The subjects came…
NEW YORK (Reuters Health) – Four clinical factors can help rule out bacterial conjunctivitis in children, New York City researchers say. The four factors are: age at least…
NEW YORK (Reuters Health) – Thrombolysis is a must for female stroke patients if they are to achieve the same outcomes as men, according to a March 2nd…
NEW YORK (Reuters Health) – Montelukast (Singulair), a leukotriene receptor antagonist, can help prevent recurrent wheezing episodes after respiratory syncytial virus (RSV) bronchiolitis, new research shows. From earlier…
NEW YORK (Reuters Health) – Interim data from a 3-year trial of stenting versus endarterectomy for symptomatic carotid stenosis suggests that for now at least, surgery should remain…
NEW YORK (Reuters Health) – Patients with aortoiliac peripheral arterial disease (PAD) have worse event-free survival than patients with more distal PAD, according to a report in the…
NEW YORK (Reuters Health) – Prophylactic antibiotics may improve survival of burn patients, a meta-analysis suggests, although the authors acknowledge that the quality of the supporting data is…
NEW YORK (Reuters Health) – Baseline platelet function is only modestly related to ischemic outcomes after percutaneous coronary intervention (PCI) in low-risk patients, according to a study in…